Current Edition

Delivering Viable, High-quality Leukapheresis Product
Volume 3 Issue 2

Delivering Viable, High-quality Leukapheresis Product via Advanced Cold Storage Solutions

Fresh leukapheresis product (LP) is a critical raw material in the global biopharmaceutical industry, being essential across many primary cell research and therapy development applications. …

Continue Reading →
Exosome Therapeutics
Volume 3 Issue 2

Exosome Therapeutics: Academic Curiosity or Commercial Reality?

Cell and gene therapies have been called the emerging fourth pillar of healthcare systems. However, recent research suggests that the cell therapy pillar may, in …

Continue Reading →
Non-clinical Safety Evaluation of Vaccine Strategic
Volume 3 Issue 2

Non-clinical Safety Evaluation of Vaccine: Strategic Considerations to Accelerate Clinical Development

Vaccines are medicinal products intended to elicit (an) immune response(s) that can prevent (prophylactic vaccine) and/or lessen the severity (therapeutic vaccine) of a given disease. …

Continue Reading →
Accelerating Regenerative Medicine Approaches to Type 1
Volume 3 Issue 2

Accelerating Regenerative Medicine Approaches to Type 1 Diabetes Through Direct Cell Reprogramming

Current treatment of type 1 diabetes mellitus (T1DM) depends on the replacement of endogenous insulin by regular subcutaneous injections of exogenous insulin. Unfortunately, exogenous insulin …

Continue Reading →
Analysing Carbohydrates with Ion Chromatography
Volume 3 Issue 2

Analysing Carbohydrates with Ion Chromatography to Develop Better Vaccines

In vaccine research, where reproducibility and accuracy are of paramount importance, scientists will need to choose the most appropriate technique to examine and characterise carbohydrates …

Continue Reading →
Unlocking the Therapeutic Potential of Antimicrobial
Volume 3 Issue 2

Unlocking the Therapeutic Potential of Antimicrobial Natural Products with Synthetic Biology

Although once a mainstay of drug discovery efforts within the pharmaceutical industry, enthusiasm for the use of natural products as a starting-point for the development …

Continue Reading →
Faster Drug Discovery with Picodroplet Technologies
Volume 3 Issue 2

Faster Drug Discovery with Picodroplet Technologies

Automated platforms based on picodroplet microfluidic technologies are one of the most promising tools for improving drug discovery efficiency. By encapsulating single cells in miniaturised, …

Continue Reading →
Ensuring Reproducibility in Biomedical Research
Volume 3 Issue 2

Ensuring Reproducibility in Biomedical Research – The Role of Data, Metadata, and Emerging Best Practices

Science is built upon continuous cycles of generating hypotheses, testing them, and refining the models based on the findings. Over many years of continuous research, …

Continue Reading →
Re-programming CHO by Gene Editing, the New Frontier
Volume 3 Issue 2

Re-programming CHO by Gene Editing, the New Frontier in Bioprocessing

Since the approval of the first recombinant biotherapeutic, insulin, in 1982, the pharmaceutical industry has experienced an explosion in the development and commercialisation of protein …

Continue Reading →
Addressing the Challenges of Selective and Sensitive
Volume 3 Issue 2

Addressing the Challenges of Selective and Sensitive Bioanalytical Assay Development

Antibodies have evolved over millions of years to become a critical component of immunity, but in a few short decades we have dramatically expanded their …

Continue Reading →
The Power of Recombinant Human Albumin
Volume 3 Issue 2

The Power of Recombinant Human Albumin New Advances in Cell Therapy Optimisation, Cryopreservation and Formulation for Novel Therapies

The pharmaceutical and biotech industry is changing. We have already seen a shift from small molecule-based drugs to more complex biologics, but now a range …

Continue Reading →
Patenting Antibodies at the European Patent Office
Volume 3 Issue 2

Patenting Antibodies at the European Patent Office

With antibodies accounting for seven out of the top ten global drugs, it is of critical importance that those companies that invest huge sums of …

Continue Reading →
Building a Patient-centric CGT Supply Chain
Volume 3 Issue 2

Building a Patient-centric CGT Supply Chain

As more cell and gene therapies (CGT) move toward commercial production, biopharmaceutical innovators developing these potentially life-saving treatments will need reliable, fast, and efficient technologies …

Continue Reading →